The Uromigos
The Uromigos
Advertisement
The UromigosThe Uromigos | January 31, 2023
Petros Grivas, MD, PhD, joins The Uromigos to discuss the use of antibody drug conjugates in bladder cancer.
Listen Now
The UromigosThe Uromigos | January 23, 2023
A summary of the prostate and bladder cancer session of the Conversations & Trending Topics in GU Cancers conference.
The UromigosThe Uromigos | January 23, 2023
A summary of the renal cancer session of the Conversations & Trending Topics in GU Cancers conference in the Canary Islands.
The UromigosThe Uromigos | January 9, 2023
Sam Chang, MD, MBA, joins The Uromigos to discuss the results of IL-15RαFc superagonist N-803 for papillary NMIBC.
The UromigosThe Uromigos | January 3, 2023
Chris Sweeney, MBBS, joins The Uromigos to discuss 2022 research as well as further studies to be carried out in 2023.
The UromigosThe Uromigos | January 3, 2023
Monty Pal, MD, FASCO, discusses his recent study on the use of novel CAR T-cell therapy for renal cell carcinoma.
The UromigosThe Uromigos | December 28, 2022
Drs. Silke Gillessen and Dan George debate the use of olaparib and abiraterone in selected or unselected patients with mCRPC.
The UromigosThe Uromigos | December 20, 2022
Is cisplatin any different from carboplatin in advanced bladder cancer? The Uromigos debate the topic with Matt Galsky, MD.
The UromigosThe Uromigos | December 12, 2022
David McDermott, MD, debates the role of ipilimumab for clear cell renal cancer with Uromigos host Brian Rini, MD.
The UromigosThe Uromigos | December 5, 2022
Pavlos Msaouel chats with The Uromigos about his editorial on the results of the recent COSMIC-313 trial.
The UromigosThe Uromigos | November 28, 2022
The Uromigos chat with Dan Shapiro, Assistant Professor of Urologic Oncology, on his work in renal medullary carcinoma.
The UromigosThe Uromigos | November 28, 2022
Dr. Andrea Necchi describes his recent phase 2 study on the use of neoadjuvant pembrolizumab and nab-paclitaxel for MIBC.
The UromigosThe Uromigos | November 14, 2022
The Uromigos chat with Scott M. Haake for the second episode of their Rising Star series and discuss his latest project.
The UromigosThe Uromigos | November 14, 2022
The Rising Star series starts with Renee Saliby, a postdoctoral GU oncology research fellow at Dana-Farber Cancer Institute.
The UromigosThe Uromigos | November 7, 2022
The Uromigos chat with Axel Merseburger about his paper on continuing enzalutamide with docetaxel for the treatment of CRPC.
The UromigosThe Uromigos | November 2, 2022
Rob Jones discusses the current state of PARP inhibition in prostate cancer as well as differing opinions on the treatment.
The UromigosThe Uromigos | October 25, 2022
Elizabeth Henske discusses her latest paper on the biology of this rare form of renal cell carcinoma. 
The UromigosThe Uromigos | October 25, 2022
Silke Gillessen and Nick James discuss a randomized trial on duration of adjuvant/salvage androgen ablation with XRT. 
The UromigosThe Uromigos | October 25, 2022
The Uromigos chat with Cora Sternberg on her paper on FGFR inhibition in advanced urothelial cancer.
Emily MenendezUromigos Live and Unplugged | September 26, 2022
Join us for The Uromigos Live & Unplugged in Nashville, Tennessee, September 30 through October 1, at the Thompson Nashville.
Advertisement
Advertisement
Advertisement